	Passifs Courants		Date
Acadia Pharmaceuticals	USD 356.58M	26.56M	2025-09
Agios Pharmaceuticals	USD 74.76M	4.35M	2025-09
Amgen	USD 21.79B	1.32B	2025-09
AstraZeneca	USD 34.05B	518M	2025-09
Bayer	EUR 28.96B	825M	2025-09
BioMarin Pharmaceutical	USD 798.44M	114.19M	2025-09
Bristol-Myers Squibb	USD 28.14B	608M	2025-09
Cytokinetics	USD 142.14M	11.08M	2025-09
Eisai	JPY 378.25B	33.36B	2025-09
Eli Lilly	USD 40.14B	1.12B	2025-09
Exelixis	USD 373.78M	37.67M	2025-09
Genmab	DKK 629M	127M	2025-06
Glaxosmithkline	GBP 28.68B	8.3B	2025-09
Incyte	USD 1.34B	60.11M	2025-09
Ionis Pharmaceuticals	USD 903.46M	6.22M	2025-09
MacroGenics	USD 44.47M	5.47M	2025-09
Merck	USD 28.63B	2.59B	2025-09
Moderna	USD 1.68B	109M	2025-09
Neurocrine Biosciences	USD 638M	91.7M	2025-09
Novartis	USD 32B	286M	2025-09
Pfizer	USD 36.6B	1.13B	2025-09
Sanofi	EUR 28.35B	9.32B	2025-12
Takeda	JPY 2.61T	470.53B	2025-12
Ultragenyx Pharmaceutical	USD 340.02M	46.78M	2025-09
Xencor	USD 86.48M	9.6M	2025-09

Exelixis Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.